Tascenso ODT, a Bioequivalent Fingolimod Product, Now Available
Tascenso ODT (fingolimod orally disintegrating tablets) is now available for the treatment of multiple sclerosis.
Clydee Markowitz Cycle Pharmaceuticals Sclerosis Center University Of Pennsylvania Perelman School Of Medicine Director Emeritus
Source: neurologyadvisor.com